Matsuda Y, Hirata K, Inoue N, Suematsu M, Kawashima S, Akita H, Yokoyama M
No, semaglutide is not FDA-approved specifically for PWS, though it is approved for type 2 diabetes and weight management in the general population
For patients seeking personalized dosing guidance, PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after the first month), which maps 14 metabolic pathways and 150+ genetic insights to optimize treatment selection and dosing strategy
However, patients taking warfarin should have their INR monitored when starting semaglutide
On the other hand, tumor development is associated with the inactivation of Bax and the over-expression of Bcl-2 leading to an overall inhibition of apoptosis